Endomyocardial Biopsy Market Size

Endomyocardial Biopsy Market size

Endomyocardial Biopsy Market size was valued at USD 321.5 million in 2022 and is estimated to account for USD 619.2 million by 2032. An endomyocardial biopsy is a medical procedure used to obtain a small sample of tissue from the inner lining of the heart, known as the endocardium.

This procedure is typically performed to diagnose and monitor certain heart conditions, especially those that involve inflammation, infection, rejection after heart transplantation, or other disorders that affect the heart muscle or its lining. Technological advancements in medical imaging, catheterization techniques, and biopsy tools can enhance the accuracy, safety, and efficiency of endomyocardial biopsies.

The growing prevalence of cardiovascular diseases is a major driving factor for the industry. Cardiovascular diseases, such as heart failure, cardiomyopathies, and myocarditis, continue to be a significant global health concern. For instance, as per the World Health Organization (WHO), cardiac diseases are the number one cause of death globally, accounting for an estimated 20.5 million deaths in 2021. Further, the incidence of cardiovascular diseases is increasing, partially due to factors such as sedentary lifestyle, unhealthy diet, tobacco use, obesity, and an increasing aging population base.